Cargando…

Malaria in Children

This review is focused on childhood specific aspects of malaria, especially in resource-poor settings. We summarise the actual knowledge in the field of epidemiology, clinical presentation, diagnosis, management and prevention. These aspects are important as malaria is responsible for almost a quart...

Descripción completa

Detalles Bibliográficos
Autores principales: Schumacher, Richard-Fabian, Spinelli, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507524/
https://www.ncbi.nlm.nih.gov/pubmed/23205261
http://dx.doi.org/10.4084/MJHID.2012.073
_version_ 1782251076262559744
author Schumacher, Richard-Fabian
Spinelli, Elena
author_facet Schumacher, Richard-Fabian
Spinelli, Elena
author_sort Schumacher, Richard-Fabian
collection PubMed
description This review is focused on childhood specific aspects of malaria, especially in resource-poor settings. We summarise the actual knowledge in the field of epidemiology, clinical presentation, diagnosis, management and prevention. These aspects are important as malaria is responsible for almost a quarter of all child death in sub-Saharan Africa. Malaria control is thus one key intervention to reduce childhood mortality, especially as malaria is also an important risk factor for other severe infections, namely bacteraemia. In children symptoms are more varied and often mimic other common childhood illness, particularly gastroenteritis, meningitis/encephalitis, or pneumonia. Fever is the key symptom, but the characteristic regular tertian and quartan patterns are rarely observed. There are no pathognomonic features for severe malaria in this age group. The well known clinical (fever, impaired consciousness, seizures, vomiting, respiratory distress) and laboratory (severe anaemia, thrombocytopenia, hypoglycaemia, metabolic acidosis, and hyperlactataemia) features of severe falciparum malaria in children, are equally typical for severe sepsis. Appropriate therapy (considering species, resistance patterns and individual patient factors) – possibly a drug combination of an artemisinin derivative with a long-acting antimalarial drug - reduces treatment duration to only three days and should be urgently started. While waiting for the results of ongoing vaccine trials, all effort should be made to better implement other malaria-control measures like the use of treated bed-nets, repellents and new chemoprophylaxis regimens.
format Online
Article
Text
id pubmed-3507524
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Università Cattolica del Sacro Cuore
record_format MEDLINE/PubMed
spelling pubmed-35075242012-11-30 Malaria in Children Schumacher, Richard-Fabian Spinelli, Elena Mediterr J Hematol Infect Dis Review Articles This review is focused on childhood specific aspects of malaria, especially in resource-poor settings. We summarise the actual knowledge in the field of epidemiology, clinical presentation, diagnosis, management and prevention. These aspects are important as malaria is responsible for almost a quarter of all child death in sub-Saharan Africa. Malaria control is thus one key intervention to reduce childhood mortality, especially as malaria is also an important risk factor for other severe infections, namely bacteraemia. In children symptoms are more varied and often mimic other common childhood illness, particularly gastroenteritis, meningitis/encephalitis, or pneumonia. Fever is the key symptom, but the characteristic regular tertian and quartan patterns are rarely observed. There are no pathognomonic features for severe malaria in this age group. The well known clinical (fever, impaired consciousness, seizures, vomiting, respiratory distress) and laboratory (severe anaemia, thrombocytopenia, hypoglycaemia, metabolic acidosis, and hyperlactataemia) features of severe falciparum malaria in children, are equally typical for severe sepsis. Appropriate therapy (considering species, resistance patterns and individual patient factors) – possibly a drug combination of an artemisinin derivative with a long-acting antimalarial drug - reduces treatment duration to only three days and should be urgently started. While waiting for the results of ongoing vaccine trials, all effort should be made to better implement other malaria-control measures like the use of treated bed-nets, repellents and new chemoprophylaxis regimens. Università Cattolica del Sacro Cuore 2012-11-06 /pmc/articles/PMC3507524/ /pubmed/23205261 http://dx.doi.org/10.4084/MJHID.2012.073 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Articles
Schumacher, Richard-Fabian
Spinelli, Elena
Malaria in Children
title Malaria in Children
title_full Malaria in Children
title_fullStr Malaria in Children
title_full_unstemmed Malaria in Children
title_short Malaria in Children
title_sort malaria in children
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507524/
https://www.ncbi.nlm.nih.gov/pubmed/23205261
http://dx.doi.org/10.4084/MJHID.2012.073
work_keys_str_mv AT schumacherrichardfabian malariainchildren
AT spinellielena malariainchildren